Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis

OBJECTIVE: This study evaluated the efficacy associated with switching to rifaximin in patients with hepatic cirrhosis receiving kanamycin sulfate for the treatment of hepatic encephalopathy and hyperammonemia. METHODS: We included 37 patients who switched from kanamycin sulfate to rifaximin at our...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsumi, Ryoji, Suii, Hirokazu, Yamaguchi, Masakatsu, Arakawa, Tomohiro, Nakajima, Tomoaki, Kuwata, Yasuaki, Toyota, Joji, Hige, Shuhei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188012/
https://www.ncbi.nlm.nih.gov/pubmed/33361677
http://dx.doi.org/10.2169/internalmedicine.6039-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188012/
https://www.ncbi.nlm.nih.gov/pubmed/33361677
http://dx.doi.org/10.2169/internalmedicine.6039-20

Ejemplares similares